Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Y Chalandon, X Thomas, S Hayette… - Blood, The Journal …, 2015 - ashpublications.org
In this study, we randomly compared high doses of the tyrosine kinase inhibitor imatinib
combined with reduced-intensity chemotherapy (arm A) to standard imatinib/hyperCVAD …

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Y Chalandon, X Thomas, S Hayette, JM Cayuela… - …, 2015 - archive-ouverte.unige.ch
In this study, we randomly compared high doses of the tyrosine kinase inhibitor imatinib
combined with reduced-intensity chemotherapy (arm A) to standard imatinib/hyperCVAD …

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.

Y Chalandon, X Thomas, S Hayette, JM Cayuela… - Blood, 2015 - folia.unifr.ch
English In this study, we randomly compared high doses of the tyrosine kinase inhibitor
imatinib combined with reduced-intensity chemotherapy (arm A) to standard …

[PDF][PDF] Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Y Chalandon, X Thomas, S Hayette, JM Cayuela… - 2015 - researchgate.net
The Philadelphia chromosome (Ph) derives from the balanced t (9; 22)(q34; q11. 2)
chromosomal translocation, resulting in the BCR-ABL1 fusion gene encoding an …

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.

Y Chalandon, X Thomas, S Hayette, JM Cayuela… - Blood, 2015 - sonar.ch
English In this study, we randomly compared high doses of the tyrosine kinase inhibitor
imatinib combined with reduced-intensity chemotherapy (arm A) to standard …

[PDF][PDF] Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Y Chalandon, X Thomas, S Hayette, JM Cayuela… - 2015 - access.archive-ouverte.unige.ch
The Philadelphia chromosome (Ph) derives from the balanced t (9; 22)(q34; q11. 2)
chromosomal translocation, resulting in the BCR-ABL1 fusion gene encoding an …

[HTML][HTML] Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Y Chalandon, X Thomas, S Hayette, JM Cayuela… - Blood, 2015 - Elsevier
In this study, we randomly compared high doses of the tyrosine kinase inhibitor imatinib
combined with reduced-intensity chemotherapy (arm A) to standard imatinib/hyperCVAD …

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.

Y Chalandon, X Thomas, S Hayette - leukemia-cell.org
Metody: Ve studii GRAAPH-2005 autoři porovnali léčbu vysokými dávkami TKI imatinibu
kombinovaného s chemoterapií s redukovanou intenzitou (vinkristin a …

[PDF][PDF] Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

Y Chalandon, X Thomas, S Hayette, JM Cayuela… - 2015 - academia.edu
The Philadelphia chromosome (Ph) derives from the balanced t (9; 22)(q34; q11. 2)
chromosomal translocation, resulting in the BCR-ABL1 fusion gene encoding an …

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.

Y Chalandon, X Thomas, S Hayette, JM Cayuela… - Blood, 2015 - europepmc.org
Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with
Ph-positive acute lymphoblastic leukemia. - Abstract - Europe PMC Sign in | Create an account …